Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Nov 22, 2024$748.01
P/E Ratio
81.83
Market Cap
$710.1B
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Overview
Trading Information
Company